SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
27-Mar-23 7:54 PM View: | Calcimedica, Inc. (CALC) | 23-Mar-23 | Disposition | 1,429 | -- | -- | 100% 0 to 1.43K | |
03-Mar-23 4:55 PM View: | Bausch & Lomb Corp (BLCO) | 01-Mar-23 | Grant | 28,344 | -- | -- | 24% 118.33K to 146.68K | |
27-Jul-22 7:38 PM View: | Bausch & Lomb Corp (BLCO) | 25-Jul-22 | Grant | 35,000 | -- | -- | 42% 83.33K to 118.33K | |
09-May-22 6:46 PM View: | Bausch & Lomb Corp (BLCO) | 05-May-22 | Grant | 83,333 | -- | -- | 100% 0 to 83.33K | |
11-Mar-22 4:00 PM View: | Valeant Pharmaceuticals Int... (BHC) | 10-Mar-22 | Payment of Exercise | 839 | $22.56 | $18,927.80 | (< 1%) 163.08K to 162.24K | 3% |
07-Mar-22 5:45 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Mar-22 | Payment of Exercise | 6,926 | $23.61 | $163,523.00 | (4%) 170.0K to 163.08K | |
02-Mar-22 9:06 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Feb-22 | Payment of Exercise | 16,028 | $24.35 | $390,282.00 | (9%) 186.03K to 170.0K | |
02-Mar-22 9:06 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Feb-22 | Option Exercise | 24,292 | -- | -- | 15% 161.74K to 186.03K | |
31-Aug-21 4:07 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Aug-21 | Payment of Exercise | 5,017 | $28.95 | $145,242.00 | (3%) 166.76K to 161.74K | |
04-Jun-21 4:51 PM View: | Valeant Pharmaceuticals Int... (BHC) | 02-Jun-21 | Option Exercise | 121,198 | $14.85 | $1,800,030.00 | 73% 166.76K to 287.96K | |
04-Jun-21 4:51 PM View: | Valeant Pharmaceuticals Int... (BHC) | 02-Jun-21 | Option Sale | 121,198 | $31.83 | $3,857,730.00 | (42%) 287.96K to 166.76K | |
15-Mar-21 4:08 PM View: | Valeant Pharmaceuticals Int... (BHC) | 11-Mar-21 | Payment of Exercise | 796 | $32.82 | $26,124.70 | (< 1%) 167.55K to 166.76K | |
10-Mar-21 8:46 PM View: | Valeant Pharmaceuticals Int... (BHC) | 10-Mar-21 | Payment of Exercise | 21,960 | $32.97 | $724,021.00 | (12%) 189.51K to 167.55K | |
10-Mar-21 8:46 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Mar-21 | Grant | 25,980 | -- | -- | 17% 155.08K to 181.06K | |
10-Mar-21 8:46 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Mar-21 | Option Exercise | 8,455 | -- | -- | 5% 181.06K to 189.51K | |
05-Mar-21 5:45 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Mar-21 | Grant | 36,250 | -- | -- | 31% 118.83K to 155.08K | |
03-Mar-21 4:26 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Mar-21 | Payment of Exercise | 5,367 | $31.42 | $168,631.00 | (4%) 124.2K to 118.83K | |
31-Aug-20 6:44 PM View: | Valeant Pharmaceuticals Int... (BHC) | 28-Aug-20 | Grant | 28,171 | -- | -- | 29% 96.03K to 124.2K | |
11-Mar-20 8:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 10-Mar-20 | Grant | 4,390 | -- | -- | 5% 87.25K to 91.64K | |
11-Mar-20 8:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 10-Mar-20 | Purchase | 4,390 | $18.25 | $80,105.60 | 5% 91.64K to 96.03K | |
11-Mar-20 8:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 09-Mar-20 | Payment of Exercise | 3,343 | $20.96 | $70,069.30 | (4%) 90.59K to 87.25K | (4%) |
03-Mar-20 4:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 28-Feb-20 | Payment of Exercise | 3,779 | $24.44 | $92,358.80 | (4%) 94.37K to 90.59K | |
28-Feb-20 7:19 PM View: | Valeant Pharmaceuticals Int... (BHC) | 26-Feb-20 | Grant | 19,449 | -- | -- | 26% 74.92K to 94.37K | |
21-Feb-20 9:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 20-Feb-20 | Payment of Exercise | 22,378 | $26.46 | $592,122.00 | (27%) 81.57K to 59.19K | |
21-Feb-20 9:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 19-Feb-20 | Grant | 42,267 | -- | -- | 90% 47.16K to 89.43K | |
21-Feb-20 9:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 19-Feb-20 | Option Exercise | 7,864 | -- | -- | (9%) 89.43K to 81.57K | |
09-Jan-20 4:17 PM View: | Valeant Pharmaceuticals Int... (BHC) | 07-Jan-20 | Payment of Exercise | 3,360 | $29.42 | $98,851.20 | (7%) 50.52K to 47.16K | |
13-Aug-19 4:03 PM View: | Valeant Pharmaceuticals Int... (BHC) | 12-Aug-19 | Market Sale (Planned) | 3,418 | $22.45 | $76,725.60 | (6%) 53.94K to 50.52K | 3% |
13-Aug-19 4:03 PM View: | Valeant Pharmaceuticals Int... (BHC) | 09-Aug-19 | Payment of Exercise | 7,779 | $22.39 | $174,172.00 | (13%) 61.72K to 53.94K | 3% |
15-Jul-19 4:30 PM View: | Valeant Pharmaceuticals Int... (BHC) | 11-Jul-19 | Private Sale (Planned) | 3,968 | $24.81 | $98,446.10 | (6%) 65.69K to 61.72K | |
12-Mar-19 4:17 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Mar-19 | Payment of Exercise | 3,630 | $23.56 | $85,522.80 | (5%) 69.32K to 65.69K | < 1% |
01-Mar-19 4:57 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Feb-19 | Grant | 21,310 | -- | -- | 44% 48.01K to 69.32K | |
10-Jan-19 4:02 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Jan-19 | Payment of Exercise | 3,446 | $21.25 | $73,227.50 | (7%) 51.46K to 48.01K | (12%) |
17-Oct-18 4:15 PM View: | Valeant Pharmaceuticals Int... (BHC) | 16-Oct-18 | Market Sale (Planned) | 4,542 | $25.50 | $115,821.00 | (8%) 56.0K to 51.46K | 7% |
17-Oct-18 4:15 PM View: | Valeant Pharmaceuticals Int... (BHC) | 15-Oct-18 | Market Sale (Planned) | 15,404 | $24.83 | $382,481.00 | (22%) 71.4K to 56.0K | 5% |
13-Aug-18 5:04 PM View: | Valeant Pharmaceuticals Int... (BHC) | 09-Aug-18 | Payment of Exercise | 7,779 | $23.52 | $182,962.00 | (10%) 79.18K to 71.4K | (< 1%) |
09-Mar-18 8:54 PM View: | Valeant Pharmaceuticals Int... (BHC) | 07-Mar-18 | Grant | 20,457 | -- | -- | 35% 58.72K to 79.18K | |
09-Jan-18 3:25 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Jan-18 | Payment of Exercise | 3,649 | $23.85 | $87,028.60 | (6%) 62.37K to 58.72K | < 1% |
11-Aug-17 4:41 PM View: | Valeant Pharmaceuticals Int... (BHC) | 09-Aug-17 | Payment of Exercise | 6,046 | $15.37 | $92,927.00 | (9%) 68.42K to 62.37K | (54%) |
10-Jan-17 7:01 PM View: | Valeant Pharmaceuticals Int... (BHC) | 06-Jan-17 | Grant | 24,575 | -- | -- | 56% 43.84K to 68.42K | |
10-Aug-16 7:33 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Aug-16 | Grant | 122,762 | -- | -- | 100% 0 to 122.76K |